The ahpC genes of 57 clinical isolates and one in vitro mutant of Mycobacterium tuberculosis were evaluated by nucleotide sequence analyses. Although compensatory ahpC promoter mutations were identified in 8 catalase-negative, katG-defective strains, the ahpC genes of 25 catalase-positive, isoniazid-resistant isolates and 25 drug-sensitive strains were not altered.
The mechanism of resistance to isoniazid (INH), the most effective and affordable agent for the treatment of tuberculosis, have not been defined in all Mycobacterium tuberculosis strains with reduced sensitivity to this drug. Mutations in the katG gene, encoding a catalase-peroxidase, or in the inhA locus, encoding a mycolic acid biosynthetic pathway enzyme, have been associated with resistance to INH in about 70% of M. tuberculosis strains (1, 3, 6, 7) . Recent studies showing that overexpression of alkyl hydroperoxide reductase (AhpC) increases the MIC of INH for M. smegmatis have suggested that ahpC gene alterations may be a factor in INH resistance in the remaining M. tuberculosis strains (2, 14) . Mutations in the ahpC promoter of katG-defective, catalase-negative, INH-resistant M. tuberculosis strains have been identified which enhance ahpC gene transcription and are apparently necessary to compensate for the loss of catalase-peroxidase activity (4, 10, 12) . However, these mutations have not been shown to alter sensitivity to INH.
To further examine whether perturbations in the ahpC gene are associated with INH sensitivity in M. tuberculosis isolates, we examined strains with the following phenotypes: 8 catalasenegative, INH-resistant; 25 catalase-positive, INH-resistant; and 25 catalase-positive, INH-sensitive strains of M. tuberculosis. Fifty-seven of the strains analyzed were clinical isolates from Korea, Brazil, Mexico, China, and the United States, and the other strain (ATCC 35829) was an INH-resistant in vitro mutant of M. tuberculosis H37Rv. The INH MICs for and the catalase activities of these strains were determined as described previously (9) . For all 58 strains, the 105-bp oxyR-ahpC intergenic region (containing the ahpC promoter) was amplified by PCR using Taq polymerase and primers designed from the published ahpC gene sequence (AHPC1 [5Ј-CCGCAACG TCGACTGGCTCA-3Ј] and AHPC2 [5Ј-ATTGATCGCCAA TGGTAAGC-3Ј]), cloned into the TA vector (Invitrogen, Carlsbad, Calif.), and analyzed for nucleotide sequence alterations with the BstI Polymerase system (Bio-Rad, Richmond, Calif.) (11) . To confirm the mutational analyses, at least two clones of each construct were sequenced. The 588-bp ahpC coding sequence of each of these isolates was evaluated by nucleotide sequencing after PCR amplification with primers AHPC3 (5Ј-ATGCATTGTCCGCTTTGATG-3Ј) and AHPC4 (5Ј-TTCTA TACTCATTGATT-3Ј). The katG and inhA loci of each strain were analyzed by PCR-single-stranded conformational polymorphism (SSCP) analysis, as described previously (6) . Although various katG genotypes were identified, each strain had a wild-type inhA gene.
As seen in Table 1 , all eight of the catalase-negative strains evaluated were highly resistant to INH, with MICs ranging from 10 to 125 g/ml. Moreover, mutations that altered the KatG protein coding sequence were detected in all of these INH-resistant strains. Deletions were detected in three strains (K10, K23, and K29), a single-base-pair insertion was found in isolate K4, a nonsense mutation was detected in strain 35829, and missense mutations were identified in the other three isolates (K20, K28, and M8).
Nucleotide sequence analyses of the intergenic region upstream of the putative ahpC initiation codon demonstrated that all of the catalase-negative M. tuberculosis strains examined have alterations in ahpC regulatory sequences ( Table 1) . The promoter mutations were found at Ϫ6, Ϫ9, Ϫ10, Ϫ12, Ϫ30, and Ϫ42 (a novel T3C substitution) relative to the putative transcription initiation site (15) . Previous promoter fusion, immunoblotting, and two-dimensional gel electrophoresis studies have shown that the same ahpC regulatory region mutations at Ϫ6, Ϫ9, and Ϫ12 result in upregulation of AhpC expression (10) . The effects of the ahpC promoter mutations at Ϫ10, Ϫ30, and Ϫ42 on AhpC expression were investigated by subjecting cell extracts of K10 (C3T, Ϫ10), K28 (C3T, Ϫ30), and 35829 (T3C, Ϫ42) to immunoblot analysis with an antibody which recognizes mycobacterial AhpC (2, 12, 13). As seen in Fig. 1 crease in AhpC levels have been demonstrated under the conditions assayed (12) .
The second set of strains examined were 25 INH-resistant, catalase-positive clinical isolates. The INH MICs for these isolates were 1 to 2 g/ml. Although katG perturbations were not detected in 15 catalase-positive, INH-resistant strains by PCR-SSCP analysis, the following missense mutations in katG were identified in the remaining 10 strains: 6 had R3L codon 463 mutations, 2 were altered at codon 315 (S3T), 1 was mutated at codon 334 (I3T), and 1 had a G3S codon 629 substitution. Nucleotide sequence analyses of these 25 isolates revealed no mutations in either the ahpC coding sequence or the oxyR-ahpC intergenic region. This result was not surprising for strains with wild-type katG genes or for isolates with codon 463 mutations. Recent studies have demonstrated that the codon 463 R3L alteration, the most common katG perturbation identified in INH-resistant M. tuberculosis strains, has little effect on enzymatic activity, and hence, ahpC compensatory mutations would not be expected (5, 8) . Furthermore, the absence of ahpC mutations in the two codon 315 mutants examined in this study is consistent with previous observations on four other S3T codon 315 INH-resistant strains (12) . Although the S3T substitution at this codon causes a 5-to 20-fold decrease in catalase-peroxidase activity, the residual enzymatic activity remaining in these mutants is apparently sufficient to allow in vivo survival in the absence of compensatory ahpC upregulation (3, 8) . As controls, 25 INH-sensitive, catalase-positive clinical isolates were evaluated for ahpC gene alterations. No mutations were detected in the ahpC regulatory and coding sequences of these drug-sensitive strains.
In summary, our analysis of the ahpC regulatory and coding sequences of 58 M. tuberculosis isolates from geographically diverse locations supports the compensatory role of ahpC promoter mutations in katG-defective, catalase-negative tubercle bacilli. However, our failure to detect ahpC regulatory or coding sequence mutations in the catalase-positive, INH-resistant clinical isolates, especially those with wild-type katG and inhA gene loci, argues against the involvement of ahpC gene mutations in INH resistance. The mechanism(s) of INH resistance in M. tuberculosis isolates lacking alterations in katG or inhA remains unresolved and demands further careful investigation. a Numbering of the ahpC promoter region nucleotides is based on the transcription start site, which is underlined and has been designated position 0. Nucleotides 5Ј to the transcription initiation site have been given a negative numerical designation.
